Cas 406496-44-4,4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile

406496-44-4

Post Buying Request

Basic information

Product Name: 4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile
Synonyms: 4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile
CAS NO:406496-44-4
Molecular Formula:
Molecular Weight: 383.834
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile(CAS DataBase Reference)
NIST Chemistry Reference: 4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile(406496-44-4)
EPA Substance Registry System: 4-({4-[2-(4-chlorophenoxy)acetyl]-2-oxopiperazinyl}methyl)benzenecarbonitrile(406496-44-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 406496-44-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

406496-44-4 Suppliers

Recommended suppliers

406496-44-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 406496-44-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,6,4,9 and 6 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 406496-44:
(8*4)+(7*0)+(6*6)+(5*4)+(4*9)+(3*6)+(2*4)+(1*4)=154
154 % 10 = 4
So 406496-44-4 is a valid CAS Registry Number.

406496-44-4Upstream product

406496-44-4Downstream Products

406496-44-4Relevant academic research and scientific papers

Piperazin-2-one amides as inhibitors of factor xa

-

, (2008/06/13)

Novel piperazin-2-one containing compounds of general formulae (I) or (II), including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivative having activity against mammalian factor Xa arc described. Compositions containing such compounds are also described. The compounds and the compositions are useful in vitro or in vivo for preventing or treating conditions in mammals characterized by undesired thrombosis.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 406496-44-4